Table 4.
Changes in 5-year relative survival (%) for the most common cancers, all stages, all ages, SEER 9*, 1975–2012
| Cancer site | 5-y relative survival (95% CI) |
Change over time (95% CI) |
||
|---|---|---|---|---|
| 1975–1977 | 2006–2012 | Absolute, % | Proportional, % | |
| All sites (case-mix adjusted) | 50.3 (50.1 to 50.6) | 66.4 (66.2 to 66.5) | 16.0 (15.7 to 16.3) | 31.9 (31.1 to 32.6) |
| Lung and bronchus | 12.2 (11.8 to 12.6) | 18.7 (18.4 to 19.1) | 6.5 (6.0 to 7.1) | 53.6 (47.5 to 59.7) |
| Colon and rectum | 49.8 (49.1 to 50.6) | 66.2 (65.7 to 66.7) | 16.4 (15.5 to 17.3) | 32.9 (30.7 to 35.1) |
| Breast (female) | 74.8 (74.2 to 75.5) | 90.8 (90.5 to 91.1) | 16.0 (15.3 to 16.7) | 21.4 (20.3 to 22.5) |
| Prostate | 67.8 (66.7 to 68.9) | 99.3 (99.1 to 99.5) | 31.5 (30.4 to 32.6) | 46.5 (44.2 to 48.9) |
| Oral cavity and pharynx | 52.5 (51.1 to 54.0) | 67.0 (66.1 to 67.9) | 14.4 (12.7 to 16.1) | 27.4 (23.5 to 31.4) |
| Esophagus | 5.0 (4.0 to 6.2) | 20.5 (19.4 to 21.7) | 15.5 (13.9 to 17.1) | 308.1 (217.6 to 398.6) |
| Stomach | 15.2 (14.1 to 16.3) | 31.1 (30.1 to 32.2) | 15.9 (14.4 to 17.4) | 104.7 (88.2 to 121.1) |
| Pancreas | 2.5 (2.0 to 3.0) | 8.5 (8.0 to 9.0) | 6.0 (5.3 to 6.7) | 244.7 (175.9 to 313.5) |
| Liver and intrahepatic bile duct | 3.4 (2.4 to 4.7) | 18.1 (17.3 to 18.9) | 14.6 (13.3 to 16.0) | 427.6 (251.4 to 603.9) |
| Urinary bladder | 72.3 (70.9 to 73.6) | 78.5 (77.7 to 79.2) | 6.2 (4.6 to 7.7) | 8.5 (6.3 to 10.8) |
| Kidney and renal pelvis | 50.1 (48.1 to 52.0) | 74.7 (73.9 to 75.4) | 24.6 (22.6 to 26.7) | 49.2 (43.3 to 55.1) |
| Melanoma of the skin | 81.9 (80.4 to 83.3) | 93.2 (92.6 to 93.6) | 11.3 (9.8 to 12.8) | 13.8 (11.7 to 15.8) |
| Cervix uteri | 69.1 (67.4 to 70.7) | 68.8 (67.4 to 70.2) | −0.3 (−2.4 to 1.8) | −0.4 (−3.5 to 2.7) |
| Corpus and uterus, NOS | 86.9 (86.0 to 87.7) | 83.4 (82.7 to 84.0) | −3.5 (−4.6 to −2.4) | −4.0 (−5.3 to −2.8) |
| Ovary | 36.0 (34.5 to 37.6) | 46.4 (45.3 to 47.6) | 10.4 (8.5 to 12.3) | 28.9 (22.5 to 35.3) |
| Non-Hodgkin lymphoma | 46.5 (45.0 to 48.0) | 72.6 (71.9 to 73.2) | 26.1 (24.4 to 27.7) | 56.1 (50.8 to 61.3) |
| Myeloma | 24.6 (22.6 to 26.6) | 50.2 (48.9 to 51.6) | 25.7 (23.3 to 28.1) | 104.5 (87.0 to 122.0) |
| Leukemia | 34.2 (32.8 to 35.5) | 62.7 (61.8 to 63.5) | 28.5 (26.9 to 30.1) | 83.6 (75.9 to 91.2) |
| Brain and other nervous system | 22.4 (21.0 to 23.9) | 35.0 (34.0 to 36.0) | 12.5 (10.8 to 14.3) | 55.9 (44.6 to 67.1) |
| Thyroid | 92.1 (90.7 to 93.3) | 98.3 (97.9 to 98.6) | 6.1 (4.8 to 7.4) | 6.6 (5.1 to 8.2) |
*
The Surveillance, Epidemiology, and End Results 9 registries are Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland, Seattle-Puget Sound, and Utah. CI = confidence interval; NOS = not otherwise specified; SEER = Surveillance, Epidemiology, and End Results.